Stay updated on Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial
Sign up to get notified when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.

Latest updates to the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page
- ChecktodayChange DetectedAdded a new revision tag: Revision: v3.6.3. Removed several items from the related topics section, including 'Multiple myeloma', 'related topics:', 'MedlinePlus Genetics', and the older 'Revision: v3.6.2'.SummaryDifference0.2%

- Check7 days agoChange DetectedA new Revision: v3.6.2 entry was added to the page's revision history, and the previous Revision: v3.6.0 entry was removed. This update reflects a newer version of the page's metadata without altering the content or functionality.SummaryDifference0.0%

- Check14 days agoChange DetectedA Related topics section now lists 'Multiple myeloma' and 'MedlinePlus Genetics', linking to disease context and genetics resources. This helps users access background information and genetics-related materials more easily.SummaryDifference0.1%

- Check22 days agoChange DetectedThe page now indicates that no participants are being sought, signaling that enrollment is closed. In addition, new help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, the revision note was updated to v3.6.0, and the Intervention/Treatment heading was reformatted (Intervention / Treatment removed in favor of Intervention/Treatment).SummaryDifference0.5%

- Check29 days agoChange DetectedThe page's revision metadata was updated to v3.5.5, and the previous revision tag v3.5.4 was removed. Related topics entries such as 'Multiple myeloma' and 'MedlinePlus Genetics' were removed from the topics list.SummaryDifference0.2%

- Check36 days agoChange DetectedThe related topics section now lists 'Multiple myeloma' and 'MedlinePlus Genetics', connecting the study to broader disease and genetics information.SummaryDifference0.1%

Stay in the know with updates to Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.